NCT03448939View on ClinicalTrials.gov

A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

361

Participants

Timeline

Start Date

June 18, 2018

Primary Completion Date

May 24, 2019

Study Completion Date

May 24, 2019

Conditions
Papulopustular Rosacea
Interventions
DRUG

S5G4T-1

Once a day topical cream

DRUG

S5G4T-2

Once a day topical cream

Trial Locations (1)

33607

Sol-Gel, Tampa

All Listed Sponsors
lead

Sol-Gel Technologies, Ltd.

INDUSTRY

NCT03448939 - A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea | Biotech Hunter | Biotech Hunter